OSE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - OSE Immunotherapeutics SA

Watchlist Manager

Watchlist

Price: 2.124 EUR 3.21% Market Closed

Market Cap: €50m

	OSE Immunotherapeutics SA PAR:OSE	FR
E	Enlivex Ltd SWB:1BT	IL
C	China BlueChemical Ltd OTC:CBLUF	CN
R	Ramada Investimentos e Industria SA F:Y4E	PT
	LFTD Partners Inc OTC:LIFD	US
	Centaurus Metals Ltd ASX:CTM	AU
T	Trans-China Automotive Holdings Ltd SGX:VI2	HK
	CVB Financial Corp NASDAQ:CVBF	US
	Goldrea Resources Corp OTC:GORAF	CA
	Upexi Inc NASDAQ:UPXI	US

Profitability Summary

OSE Immunotherapeutics SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 359%

Negative 3Y Average Operating Margin

-777%

Declining Operating Margin

-811% > -1 359%

Negative Net Margin

-1 401%

Negative 3Y Average Net Margin

-781%

Declining Net Margin

-769% > -1 401%

Negative Free Cash Flow Margin

-1 268%

Negative 3Y Average Free Cash Flow Margin

-744%

Declining Free Cash Flow Margin

-784% > -1 268%

Negative ROE

-82%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-3%

Declining ROIC

-51% > -70%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.